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Abstract
A progressive post-onset decrease in gray matter volume 1.5 years after first hospitalization in
schizophrenia has been shown in superior temporal gyrus (STG). However, it is still controversial
whether progressive volume reduction occurs in chronic schizophrenia in the STG and amygdala–
hippocampal complex (AHC), structures found to be abnormal in chronic schizophrenia. These
structures were measured at two time points in 16 chronic schizophrenia patients and 20 normal
comparison subjects using manual tracing with high spatial resolution magnetic resonance imaging
(MRI).Average interscan interval was 3.1 years for schizophrenia patients and 1.4 years for healthy
comparison subjects.
Cross-sectional comparisons showed smaller relative volumes in schizophrenia compared with
controls in posterior STG and AHC. An ANCOVA with interscan interval as a covariate showed
there was no statistically significant progression of volume reduction in either the STG or AHC in
the schizophrenia group compared with normal subjects. In the schizophrenia group, volume change
in the left anterior AHC significantly correlated with PANSS negative symptoms. These data, and
separately reported first episode data from our laboratory, suggest marked progression at the initial
stage of schizophrenia, but less in chronic schizophrenia.
© 2009 Elsevier B.V. All rights reserved.
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1. Introduction
Abnormalities in superior temporal gyrus (STG) gray matter and amygdala–hippocampal
complex (AHC) are among the most consistently documented findings of schizophrenia in
structural magnetic resonance imaging (MRI) studies (Honea et al., 2005; Shenton et al.,
2001; Wright et al., 2000). Functionally, the STG includes primary and secondary auditory
cortices and a language-related area, while the amygdala and hippocampus are critical for
memory functions (Squire and Zola, 1996) and affect perception (Morris et al., 1996). Volume
reduction in STG has been associated with auditory hallucinations (Barta et al., 1990) and
thought disorder (Shenton et al., 1992) while volume reduction in AHC has been associated
with negative symptoms (Anderson et al., 2002). The significance of these structures has been
also highlighted by functional MRI reports of STG and AHC abnormalities in auditory
perception, language, and memory tasks (Blakemore and Frith, 2000).
Several prospective longitudinal studies suggest progression of gray matter volume reduction
in schizophrenia in the period just following onset (Nakamura et al., 2007). Greater gray matter
decline in left posterior STG was found in schizophrenia patients 1.5 years after first
hospitalization but not in patients with affective psychosis and controls (Kasai et al., 2003a).
Progressive volume reduction of temporal structures has been also reported for whole temporal
lobe (DeLisi et al., 1995), as well as Heschl's gyrus/planum temporale gray matter (Kasai et
al., 2003b). Conjoint progression of Heschl's gyrus volume loss and mismatch amplitude
decline (Salisbury et al., 2007) in first episode schizophrenia has also been reported. Moreover,
progression in temporal lobe has been reported for patients with childhood-onset schizophrenia
(Gogtay et al., 2004; Rapoport et al., 1999). In addition, reduction in left and right hemispheres
and right cerebellum have been reported (DeLisi et al.,1997). However, other studies failed to
find progressive volume reduction in temporal lobe structures, such as in temporal lobes and
hippocampus (DeLisi et al., 1997), temporal lobe and STG (DeLisi and Hoff, 2005),
hippocampal and temporal lobe volumes (Wood et al., 2001), total brain volume, hippocampus
and amygdala (Whitworth et al., 2005), and hippocampus and total cortex (J. Lieberman et al.,
2001).
The presence of progressive volume loss in chronic schizophrenia is even more controversial
with some studies finding progressive changes and others failing to find them (see Table 1 for
a comprehensive review of studies and regions involved). Among them, only two studies
showed progressive volume changes in STG in chronic schizophrenia (Mathalon et al.,
2001;van Haren et al., 2007).
Thus, the primary purpose of this study was to evaluate prospectively the presence of a
progressive volume loss in temporal structures in chronic schizophrenia. We investigated gray
matter volume of STG and AHC in chronic schizophrenia patients using high spatial resolution
contiguous MRI sections and highly reliable manual region of interest measurements of these
brain regions. The second purpose was to elucidate the relationship between volume changes
and clinical symptoms as measured with the Positive and Negative Symptoms Scale (PANSS).
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2. Method
2.1. Subjects
Sixteen male patients with chronic schizophrenia and 20 healthy male comparison subjects
participated in this study. Patients were recruited from the VA Boston Healthcare System-
Brockton Division. The comparison subjects were recruited through newspaper
advertisements. After a complete description of the study, written informed consent was
obtained from all participants.
Demographic data for subjects in each group are presented in Table 2. Exclusion criteria for
both groups were: 1) neurological illness or major head trauma, 2) previous treatment with
electric convulsive therapy (ECT), 3) any history of alcohol or drug dependence, or 4) alcohol
or drug abuse within the past 5 years. The age range for inclusion was 24 to 54 years.
Comparison subjects were screened with the Structured Clinical Interview for DSM-III-R
(SCID), nonpatient edition, by trained interviewers (M.E.S, P.N). No comparison subjects had
an Axis I psychiatric disorder in themselves or a first degree relative. All patients were
diagnosed with schizophrenia based on a SCID interview and a chart review by the same
interviewers. All patients were receiving neuroleptic medication (typical, N=3; atypical, N=11;
both, N=2). The mean dose was 392.8mg/day (SD=330.9) in chlorpromazine equivalents.
2.2. Clinical evaluations
Handedness was assessed with the Edinburgh Inventory (Oldfield, 1971). Subjects' and
parental socioeconomic status were measured by the Hollingshead two-factor index (1=
highest, 5=lowest). All subjects were given PANSS at initial scan (time 1) but not at rescan
(time 2) (Table 2). In the present study, we focused on correlations between regions of interest
and clinical positive and negative symptoms.
2.3. MRI image acquisition and processing
MR images were acquired with a 1.5-T General Electric scanner (GE Medical Systems,
Milwaukee) at the Brigham and Women's Hospital in Boston. Imaging methods have been
described in detail elsewhere (Wible et al., 1995). The same acquisition protocol was used at
time 1 and time 2. The acquisition protocol included two MRI pulse sequences. The first
sequence resulted in contiguous spoiled gradient-recalled images (repetition time=35 ms, echo
time=5 ms, one repetition, 45° nutation angle, 24-cm field of view, number of excitations=1,
matrix=256×256 [192 phase-encoding steps]×124). Voxels were 0.9375×0.9375×1.5 mm.
Data were formatted in the coronal plane and analyzed as 124 coronal 1.5-mm-thick slices.
The second acquisition sequence resulted in axial series of contiguous double-echo (proton
density and T2-weighted) images (repetition time=3000 ms, echo time=30 and 80 ms, 24-cm
field of view, and an interleaved acquisition with 3.0-mm slice thickness). The voxel
dimensions were 0.9375×0.9375×3.0 mm. This latter pulse sequence was used to measure the
volume of the total intracranial contents (brain, CSF, connective tissue, and blood vessels). An
anisotropic diffusion filter (Gerig et al., 1992) was applied to both spoiled gradient-recalled
and T2 images to reduce noise prior to processing. The intensity information from both the
spoiled gradient-recalled and T2 images was used in a fully automated segmentation program
to classify tissue into gray matter, white matter, and CSF. An iterative expectation–
maximization algorithm estimated image intensity inhomogeneities, applied intensity
corrections on the basis of these estimates, and then classified tissue on the basis of the same
set of signal intensity parameters for all subjects (Wells Wet al., 1996). Images were realigned
by using the line between the anterior and posterior commissures and the sagittal sulcus to
correct head tilt and then were resampled into isotropic voxels (0.9375×0.9375×0.9375
mm3). Manual drawings of regions of interest were performed on the realigned and resampled
coronal slices.
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2.4. Regions of interest
The STG and AHC were delineated manually on a work-station by a rater who was blinded to
the diagnosis and the time of scan (initial scan or rescan) with the established procedure
described in our previous report (Hirayasu et al., 1998) (Fig. 1). Three raters (TY, MN, KL)
who were blind to group membership independently drew the regions of interest on five
subjects, resulting in a high interrater reliability (left and right anterior/posterior STG, intraclass
correlation coefficients (ICC)=0.981/0.995 (left anterior/posterior) and 0.985/0.990 (right
anterior/posterior); left and right anterior/posterior AHC, ICC=0.982/0.990 (left anterior/
posterior) and 0.980/0.990 (right anterior/posterior)).
2.5. Statistical analyses
We used t-tests to assess group differences at initial scan (time 1) and rescan (time 2) in age,
handedness, socioeconomic status, parental socioeconomic status, education, WAIS-III,
interscan interval, and total intracranial contents. The interscan interval (time between time 1
and time 2) was significantly different between groups (Table 2).
2.5.1. Group differences in relative volume at time 1 and time 2 scans and
volume change over time—Cross-sectional group differences at time 1 and time 2 in
regions of interest were evaluated using relative volumes ([absolute volume of region of
interest]/[intracranial contents]× 100 (%)) we used repeated measures analysis of variance
(ANOVA) with group (schizophrenia or healthy comparison) as between-subject factor, and
region (STG or AHC), subdivision (anterior or posterior), and side (left or right) as within-
subjects factors. We evaluated volume change in regions of interest over time by using the
percent of change as the dependent variable. Percent volume change was calculated with the
following formula: ([absolute volume at time 2]−[absolute volume at time 1])/[absolute volume
at time 1]×100 (%). An analysis of covariance (ANCOVA) with interscan interval as a
covariate, group (schizophrenia or healthy comparison) as between-subject factor, subdivision
(anterior or posterior) and side (left or right) as within-subjects factors was performed for STG
and AHC, respectively. Finally, a regression analysis was performed to examine the effect of
time between two scans on the percent volume change of the anterior/posterior STG and
anterior/posterior AHC for both schizophrenia patients and healthy comparisons.
2.5.2. Correlations between percent volume change or absolute volume and
clinical measures—Spearman's correlations were used to examine correlations between
percent change and clinical symptom scales. Spearman's correlations were also used to examine
correlations between absolute volume of time 1 and clinical symptom scales. In these
exploratory analyses, we used p<0.05 as the cutoff value for statistical significance for each
region.
3. Results
3.1. Demographic and neuropsychological group differences
There were no significant group differences in age, handedness, and parental socioeconomic
status (Table 2). Patients had lower socioeconomic status, education, WAIS-III total score
relative to comparison subjects, which is consistent with a functional deterioration brought by
the disorder.
3.2. Cross-sectional differences in relative volume at time 1 and time 2
In the ANOVA with group, region (total STG or total AHC), subdivision (anterior or posterior),
and side (left or right) for relative volume at time 1 and time 2, the groups were significantly
different at both time points (time 1: F=15.51, df=1, 34, p<0.0001, time 2: F=18.30, df=1, 34,
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p<0.0001). Interaction of group by region by subdivision was significant both at time 1 and
time 2 (time 1: F=7.15, df=1, 34, p=0.01, time 2: F=5.78, df=1, 34, p=0.02). To follow-up on
this interaction, we performed ANOVA with group, subdivision, and side separately for STG
and AHC at time 1 and time 2. Interaction of group by subdivision was significant only in STG
at both time points (time 1: F=4.69, df=1, 34, p=0.04, time 2: F=6.28, df=1, 34, p=0.017). In
ANOVA with group for anterior and posterior STG, the main effect of group was significant
only in the posterior subdivision at both time points (time 1: F=7.07, df=1, 34, p=0.01, time 2:
F=8.08, df=1, 34, p=0.008) but not significant in the anterior subdivision. These results indicate
the reduced volume of bilateral posterior STG in schizophrenic patients at both time 1 and time
2 (Table 3, Fig. 2a). In AHC, we performed ANOVA with group, subdivision, and side both
at time 1 and time 2. The groups were significantly different at both time points (time 1:
F=22.81, df=1, 34, p<0.0001, time 1: F=22.95, df=1, 34, p<0.0001). There were no significant
interactions of group by subdivision at time 1 and time 2 (Table 3, Fig. 2b).
Total intracranial contents at both time 1 and time 2 were significantly smaller in schizophrenia
patients than in healthy comparison subjects (time 1: t=2.47, df=34, p=0.02, time 2: t=2.30,
df=34, p=0.03) (Table 2). At the same time, intracranial contents for each group separately
(i.e., in the within group comparisons) did not differ between time 1 and time 2 (for
schizophrenia patients: t=0.85, df=15, p=0.41; for normal comparison subjects: t=−1.08, df=19,
p=0.29).
3.3. Volume change
In STG, ANCOVA conducted on percent volume change over time with interscan interval as
a covariate and group, subdivision, and side as between- and within-subjects factors did not
show significant group differences (F=0.01, df=1, 34, p=0.91) or significant interactions (Table
3, Fig. 3a). In AHC, ANCOVA conducted on percent change over time with interscan interval
as a covariate and group, subdivision, and side showed no significant group differences
(F=0.18, df=1, 34, p=0.67) or significant interactions (Table 3, Fig. 3b). We also performed
one factor ANCOVAs on both STG and AHC (with volumes collapsed for left and right sides)
with interscan interval as covariate and group as between-subject factor. Neither region showed
significant main effect of group. Finally, we performed one factor ANCOVAs on both STG
and AHC (with volumes for left and right sides separately) with interscan interval as covariate
and group as between-subject factor. Only right posterior AHC reached a trend level (F=3.07,
df=1, 34, p=0.09) (Table 3, Fig. 3b).
In the regression analyses for schizophrenia and normal controls, there were no regions which
showed a significant relationship between volume change and interscan interval in either the
schizophrenia or normal control group. Moreover, ANOVA with group and interscan interval
to compare regression slopes between the two groups did not show significant interactions of
group by interscan interval in any of the regions.
3.4. Correlations between percent change or absolute volume and clinical measures
There were no significant correlations between percent change in the anterior, posterior, and
total regions in STG and total clinical symptom scales on PANSS. The scores of total negative
PANSS negatively correlated at trend level (rs=−0.48, p=0.06) with percent change of left
anterior AHC. Total positive PANSS scores negatively correlated with absolute volume of
time 1 in the left total STG (rs=−0.59, p=0.02). In addition, hallucinatory behavior in PANSS
(rs=−0.74, p=0.001) significantly negatively correlated with absolute volume of time 1 in the
left total STG (Fig. 4).
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4. Discussion
No statistically significant progressive volume changes over a three-year scan time interval in
STG and AHC in chronic schizophrenia were found in this study despite using the same region
of interest definitions and methodology as in Kasai et al. (2003a) that reported significant
progressive volume loss in the left STG over 1.5 year in first episode patients. Thus, given that
significant volumetric reductions were not detectable in the period twice as long as that used
in the first episode study, this result strongly suggests a greater rate of volume loss in first
episode relative to chronic schizophrenia patients. The small volume change (all ROI
reductions were less than 3.0%) and small to medium effect sizes (0.006–0.56) across all the
regions imply that, at least for the three-year interval used in this study, putative volume
reductions, if present, happen at a very slow rate. It may be the case that reductions of this
magnitude are very difficult to detect in small ROI such as STG and AHC although they may
be easier to detect with larger brain and CSF regions (DeLisi, 2008; Hulshoff Pol and Kahn,
2008). The long duration of illness in the subjects in the present study may have been an
additional reason for the small volume changes reported here.
These different rates of progression have important implications for our understanding of brain
changes in schizophrenia. Thus, for the STG, volume changes seem to be large initially after
onset and then become relatively static in a chronic phase. If this scenario is correct, it would
suggest the importance of early interventions insofar as pharmacotherapy and psychosocial
treatment can mitigate progression.
The presence of significant cross-sectional relative volume reduction in the bilateral posterior
STG at both time 1 and time 2 reported in this study is in line with previous results (Anderson
et al., 2002; Shenton et al., 2001; Wright et al., 2000). We also found significant volume
reduction in amygdala and hippocampus in schizophrenia in concordance with several previous
studies. On the other hand, some post mortem studies did not show volume reduction in
schizophrenia. However, post mortem findings could be complicated by several aging factors.
Volume change over time reached trend level in the right posterior AHC, which may imply a
slow progressive volume loss in chronic schizophrenia. A recent volumetric MRI study
reported significant association between right hippocampal volume reduction and total PANSS
change in chronic schizophrenia, suggesting the possibility of progressive reduction of right
hippocampus (Panenka et al., 2007). Only a longitudinal study with multiple measurement
points can address this possibility and such a study is currently in progress in our laboratory.
We note that limitations of this study include a small sample size, only male participants, only
two time scan points, and different interscan intervals for the patient and control groups. While
we used interscan interval as a covariate to compensate statistically for the group difference in
the interscan intervals, having the same interscan interval for both controls and patients would
have been more desirable. In addition, atypical antipsychotic administration has been reported
to be associated with changes in gray matter volume in humans, both with a possible
neuroprotective effect (Konradi and Heckers, 2001; J. A. Lieberman et al., 2005;Nakamura et
al., 2007) and also with a possible increase in gray matter loss reported in humans (Cahn et al.,
2002) and in animals (Dorph-Petersen et al., 2005). In our study, 13 out of 16 schizophrenia
patients used atypical neuroleptic drugs. Finally, because we did not measure whole brain
volume or whole brain gray matter, nor any ROI other than STG and AHC, we cannot state
whether cross-sectional volume reductions are specific to these ROIs, nor can we be sure
whether our findings are specific to the amygdala or hippocampal component of the AHC.
The precise neurobiological mechanism of structural abnormalities and their progression in
schizophrenia is unclear. However, a growing body of evidence implicates abnormal
interaction of neurons using excitatory amino acid neurotransmission and those using
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GABAergic neurotransmission (Lewis and Gonzalez-Burgos, 2006). Although still
controversial, this reduction of GABAergic neurotransmission and resulting increased
excitation is regarded as a possible cause of neuropil (dendrites and synapses) volume
reduction. Interestingly, increased levels of glutamine in medial prefrontal cortex (Bartha et
al., 1997; Olbrich et al., 2008) and anterior cingulate cortex and thalamus (Theberge et al.,
2002, 2007), glutamate in dorsolateral prefrontal cortex and hippocampus (van Elst et al.,
2005), and cerebrospinal fluid (Hashimoto et al., 2005)were found in first episode and early
schizophrenia, while lower levels of glutamine and glutamate in anterior cingulate and
thalamus (Theberge et al., 2003) and glutamate/glutamine in dorsolateral prefrontal cortex
(Ohrmann et al., 2007, 2005) were found in chronic schizophrenia. These different levels of
glutamatergic dysfunction in several regions at different stages in schizophrenia may explain
the difference between progressive volume change in the early stage of schizophrenia and a
lack of such changes in the chronic stage. Thus, in temporal lobe structures, the
pathophysiological processes may differ between the early and late stages after the onset of
psychosis in schizophrenia.
Consistent with this hypothesis, there were reports of stable longitudinal mismatch negativity
(MMN) deficits in test–retest measurements over 1–2 years duration in patients with chronic
schizophrenia (Light and Braff, 2005). This contrasts dramatically with progression of deficits
over 1.5 years in a longitudinal study of patients with initial measurements at first
hospitalization and time 2 measurements 1.5 years later (Salisbury et al., 2007). Moreover, the
Salisbury et al. (2007) study found the change in MMN to be correlated with volume reduction
in Heschl's gyrus, consistent with evidence of a MMN generator in STG (Alho, 1995; Naatanen,
1992; Sabri et al., 2004), and with NMDA as a primary neurotransmitter contributing to MMN
generation (Javitt et al., 1996; Kreitschmann-Andermahr et al., 2001; Umbricht et al., 2000).
The absence of progressive volumetric changes in the STG and stable MMN deficits in chronic
schizophrenia may thus reflect a common pathophysiological basis of increased GABAergic–
glutamatergic dysfunction in STG during the early course of schizophrenia and less in chronic
schizophrenia.
In clinical correlations, the left anterior AHC volume reduction, mainly including left
amygdala, correlated with total negative PANSS scores at trend level. This area has been
reported to be related to negative symptoms of schizophrenia (Rajarethinam et al., 2001). It is
unclear why, in our study, negative symptoms inversely correlated only with volume change
over time, but not with relative or absolute volume. However, the present findings suggest that
the volume change of the left amygdala over time may contribute to negative symptoms during
a chronic course of schizophrenia. Smaller left total STG was associated with severity of
hallucinatory behavior. Left STG has been reported to be associated with auditory
hallucinations in schizophrenia in studies using several functional modalities (Copolov et al.,
2003; Hoffman et al., 2003; Ropohl et al., 2004; van de Ven et al., 2005). Absolute volume of
the left total STG also negatively correlated with total positive PANSS scores indicating that
volume reductions of left STG may contribute to global positive symptoms in chronic
schizophrenia.
In summary, progressive volume change of the STG and AHC was not found in chronic
schizophrenia in our study suggesting that the absence of further volume reduction over time
may characterize the chronic course in schizophrenia, in contrast with peri-onset period. In
addition, percent change of left anterior AHC was correlated at trend level with negative
symptoms, which suggests an important role of this region in pathophysiology of negative
symptoms in chronic schizophrenia. The correlations between positive symptoms and the
volume of left STG highlighted its possible involvement in hallucinations. Further studies with
a follow-up over a longer period of time are needed to clarify the nature of course in
schizophrenia.
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STG, superior temporal gyrus; AHC, amygdala–hippocampal complex.
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Figure 1.
Delineation of the superior temporal gyrus gray matter and amygdala–hippocampal complex.
(a) Superior temporal gyrus (STG): the left and right STG gray matter are shown in axial view
(right anterior STG in green, right posterior STG in red, left anterior STG in light blue, and
left posterior STG in brown). (b) Amygdala–hippocampal complex (AHC): the left and right
AHC are shown in axial view (right anterior AHC in light green, right posterior AHC in yellow,
left anterior AHC in purple, and left posterior AHC in deep blue). (c) Delineation of anterior
STG and AHC in coronal view. (d) Delineation of posterior STG and AHC in coronal view.
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Figure 2.
Relative volume of the STG and AHC by hemisphere in patients with schizophrenia and healthy
comparison subjects at time 1 and time 2 (horizontal black lines indicate means).
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Figure 3.
Percent change of the STG and AHC by hemisphere in patients with schizophrenia and healthy
comparison subjects (horizontal black lines indicate means).
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Figure 4.
Correlation between percent change (left panel) or absolute volume at time 1 (middle and right
panels) and clinical measure.
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